Items where Author is "Paris, Daniel Henry"

Article

Tran, Thi Duc Hanh and Hattendorf, Jan and Do, Hung Manh and Hoang, Thanh Tien and Hoang, Hang Thi Hai and Lam, Hoa Ngoc and Huynh, Mai Kim and Vu, Lan Thi Hoang and Zinsstag, Jakob and Paris, Daniel Henry and Schelling, Esther. (2021) Ecological and behavioural risk factors of scrub typhus in central Vietnam: a case‑control study. Infectious Diseases of Poverty, 10. p. 110.

Arpagaus, Armon and Franzeck, Fabian Christoph and Sikalengo, George and Ndege, Robert and Mnzava, Dorcas and Rohacek, Martin and Hella, Jerry and Reither, Klaus and Battegay, Manuel and Glass, Tracy Renee and Paris, Daniel Henry and Bani, Farida and Rajab, Omary Ngome and Weisser, Maja and Kiularco Study Group, . (2020) Extrapulmonary tuberculosis in HIV-infected patients in rural Tanzania: the prospective Kilombero and Ulanga antiretroviral cohort. PLoS ONE, 15 (3). e0229875.

Brown, Jennifer Anne and Ringera, Isaac and Luoga, Ezekiel and Cheleboi, Molisana and Kimera, Namvua and Muhairwe, Josephine and Kayembe, Buntshi Paulin and Molapo Hlasoa, Mosa and Kabundi, Lorraine and Yav, Ching Wey David and Mothobi, Buoang and Thahane, Lineo and Amstutz, Alain and Bachmann, Nadine and Mollel, Getrud Joseph and Bresser, Moniek and Glass, Tracy Renée and Paris, Daniel Henry and Klimkait, Thomas and Weisser, Maja and Labhardt, Niklaus Daniel. (2020) Genotype-Informed Versus Empiric Management Of VirEmia (GIVE MOVE): study protocol of an open-label randomised clinical trial in children and adolescents living with HIV in Lesotho and Tanzania. BMC infectious diseases, 20. p. 773.

Mapesi, Herry and Paris, Daniel Henry. (2019) Non-communicable diseases on the Rise in sub-Saharan Africa, the underappreciated threat of a dual disease burden. PRAXIS, 108 (15). pp. 997-1005.

Neumayr, Andreas and Paris, Daniel Henry and Genton, Blaise and Hatz, Christoph. (2017) Artemether-lumefantrine treatment failure in nonimmune European travelers with P. falciparum malaria : 5.3% now and 5.3% then - need to reconsider dosing in patients from non-endemic regions? Clinical infectious diseases, 64 (10). pp. 1466-1467.